ANI Pharmaceuticals ANIP Convertible notes, net
Convertible notes, net at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept anip:ConvertibleNotesPayableNetNoncurrent.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's convertible notes, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's convertible notes, net?
- ANI Pharmaceuticals (ANIP) reported convertible notes, net of $308.47M in Q1 2026.
- How has ANI Pharmaceuticals's convertible notes, net changed year-over-year?
- ANI Pharmaceuticals's convertible notes, net increased by 0.7% year-over-year, from $306.34M to $308.47M.
- What does convertible notes, net mean?
- This represents the long-term portion of debt obligations that can be converted into equity shares of the company under specified conditions. These instruments are used to finance long-term growth while potentially diluting existing shareholders upon conversion. Investors monitor this to evaluate the company's leverage, cost of capital, and the potential impact of future equity dilution.